Abingdon Health’s core technology is based on rapid lateral flow immunoassay diagnostics and associated reader systems.
We are also developing the next generation of multiplexed rapid diagnostics technology to meet the market need for simple-to-use, rapid, cost effective, portable system.
Need a lateral flow assay quantifying? Looking for a cost-effective solution for quantitative assay development? Co… https://t.co/huEDTVDAhT
21 February 2018
© Abingdon Health 2018